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The O antigen (Oag) component of lipopolysaccharide (LPS) is a major virulence 19 
determinant of Shigella flexneri and is synthesized by the O antigen polymerase, WzySf. 20 
Oag chain length is regulated by chromosomally encoded WzzSf and pHS-2 plasmid 21 
encoded WzzpHS2. To identify functionally important amino acid residues in WzySf, random 22 
mutagenesis was performed on the wzySf in a pWaldo-TEV-GFP plasmid followed by 23 
screening with colicin E2. Analysis of the LPS conferred by mutated WzySf proteins in the 24 
wzySf deficient (∆wzy) strain identified 4 different mutant classes, with mutations found in 25 
the Periplasmic Loops (PL) - 1, 2, 3, and 6; Trans-membrane (TM) regions - 2, 4, 5, 7, 8, 26 
and 9; and Cytoplasmic Loops (CL) - 1 and 5. The association of WzySf and WzzSf was 27 
investigated by transforming these mutated wzySf plasmids into a wzySf and wzzSf deficient 28 
strain (∆wzy ∆wzz). Comparison of the LPS profiles in the ∆wzy and ∆wzy ∆wzz 29 
backgrounds identified WzySf mutants whose polymerization activity was WzzSf-dependent. 30 
Colicin E2 and bacteriophage Sf6c sensitivities were consistent with the LPS profiles. 31 
Analysis of the expression levels of the WzySf-GFP mutants in the ∆wzy and ∆wzy ∆wzz 32 
backgrounds identified a role for WzzSf in WzySf stability. Hence, in addition to its role in 33 
regulating Oag modal chain length, WzzSf also affects WzySf activity and stability.  34 







Shigella flexneri lipopolysaccharide (LPS) is crucial for pathogenesis (1). LPS is exclusively 40 
located in the outer leaflet of the outer membrane (OM) and has three domains: 1) Lipid A - 41 
a hydrophobic domain which anchors LPS to the OM, 2) the core oligosaccharides - a non-42 
repeating oligosaccharide domain, and 3) the O-antigen (Oag) polysaccharide - an 43 
oligosaccharide repeat domain (1) (2). The complete LPS structure with Oag chains is 44 
termed smooth LPS (S-LPS). However, the LPS structure lacking the Oag is termed rough 45 
LPS (R-LPS), and LPS with a single Oag tetrasaccharide repeat unit (RU) attached to the 46 
Lipid A and core sugar is termed semi-rough LPS (SR-LPS) (3). S. flexneri is subdivided 47 
into various serotypes depending on the differences in the composition of LPS Oag. So far 48 
there are 17 known serotypes of S. flexneri (4). Except for S. flexneri serotype 6, the Oag of 49 
all other serotypes has the same polysaccharide backbone containing three L-rhamnose 50 
residues (Rha), and one N-acetylglucosamine (GlcNAc). This basic Oag structure is known 51 
as serotype Y. Addition of either glucosyl, O-acetyl, or phosphoethanolamine (PEtN) groups 52 
by various linkages to the sugars of the Y serotype tetrasaccharide repeat creates different 53 
S. flexneri serotypes (5-7). Oag is the protective antigen as immunity against the S. flexneri 54 
infection is serotype specific (8, 9). S-LPS confers resistance to complement (10) and 55 
colicins (11, 12), and Y serotype Oag acts as a receptor to bacteriophage Sf6 (13).  56 
 57 
S. flexneri Oag biosynthesis occurs by the Wzy-dependent pathway. Most of the Oag 58 
biosynthesis genes (except wecA) of S. flexneri are located in the Oag biosynthesis locus 59 
between galF and his (6, 14). S. flexneri Oag biosynthesis occurs on either side of the inner 60 
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membrane (IM). Initially N-acetylglucosamine phosphate (GlcNAc-1-P) is transferred from 61 
uridine diphosphate-GlcNAc (UDP-GlcNAc) by WecA to undecaprenol phosphate (Und-P) 62 
at the cytoplasmic side of the IM (5, 15, 16). RfbG and RfbF then add Rhamnose (Rha) 63 
residues from thymidine diphospho-rhamnose (dTDP-Rha) to the GlcNAc (3, 17) to form 64 
the O unit. In the Wzy-dependent model of LPS assembly, the flippase protein Wzx 65 
translocates this O unit to the periplasmic side. At the periplasmic side, the O units are 66 
polymerized at the non-reducing end by the Oag polymerization protein Wzy via a block 67 
transfer mechanism to form the polymer. The chain length of the final Oag is regulated by 68 
the protein Wzz (3, 18). Finally, the Oag ligase WaaL ligates the Oag chains to the 69 
previously synthesized core-lipid A. The Lpt proteins (Lpt A-G) then transport the LPS from 70 
the IM to the OM (1, 19). 71 
 72 
The Oag polymerization protein WzySf is encoded by the rfc/wzy gene. WzySf is a 43.7 kDa 73 
hydrophobic integral membrane protein. It has 12 transmembrane (TM) segments and two 74 
large periplasmic (PL) domains (3, 18). Based on a topology model proposed by our group 75 
the amino and carboxy terminal ends are located on the cytoplasmic side of the IM. The 76 
wild type wzySf gene lacks a detectable ribosome binding site, has a low G+C %, and a high 77 
percentage of minor codons in the first 25 amino acids, contributing to low expression and 78 
poor detection of the protein (3, 18).  79 
 80 
Islam et al. (2011) performed extensive work on Pseudomonas aeruginosa Wzy (WzyPa) 81 
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and showed that both PL3 and PL5 of WzyPa contain RX10G motifs, which are important for 82 
the functioning of WzyPa. They also found several Arg residues within these two motifs are 83 
also important for WzyPa function (20). However there is little sequence identity between 84 
WzyPa and WzySf. So, it is not possible to predict the functional amino acid residues of 85 
WzySf from another model.   86 
 87 
Wzz is a member of the polysaccharide co-polymerase (PCP) family. S. flexneri has two 88 
types of Wzz - chromosomally encoded WzzSf and pHS-2 plasmid encoded WzzpHS2. S. 89 
flexneri 2a has S-LPS with two types of modal chain length: short (S) type (11-17 Oag RUs) 90 
and very long (VL) type (>90 Oag RUs), and the S-type and VL-type Oag chain lengths are 91 
determined by WzzSf and WzzpHS2, respectively. Controlling Oag chain length is crucial for 92 
bacterial virulence and loss of WzzSf mediated Oag modal chain length regulation affects 93 
virulence due to masking of the OM protein IcsA (21, 22). Daniels and Morona (1999) 94 
showed that WzzSf forms a dimer in vivo and may oligomerise up to a hexamer (23). 95 
Formation of these large complexes is consistent with the hypothetical complex formation 96 
between Wzz and other enzymes of the Oag biosynthesis pathway, including Wzy (14, 24). 97 
WzzSf and WzzpHS2 compete for the available WzySf (25). 98 
 99 
Woodward et al. (2010) showed that Wzz and Wzy are sufficient to determine the Oag 100 
modal chain length (26). There are several proposed mechanisms for modal length control 101 
by Wzz and its association with Wzy: a molecular clock model was proposed by Bastin et 102 
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al. (1993) (24) and a molecular chaperone model was proposed by Morona et al. (1995) 103 
(14). Tocilj et al. (2008) suggested that Wzz may form a scaffold and recruits Wzy (27). 104 
However, there is no direct evidence to date on how these proteins are associated with 105 
each other in Oag polymerization and chain length control. 106 
 107 
In this study we were able to overexpress and detect WzySf-GFP expression in S. flexneri. 108 
We performed random mutagenesis on wzySf and following screening with colicin E2, for 109 
the first time identified amino acid residues important for WzySf function. We classified the 110 
wzySf mutants based on their LPS profile. We were able to determine mutant protein 111 
expression levels, and also characterised the mutants depending on the phage and colicin 112 
sensitivities they conferred. These findings provided insight to Wzy structure and function. 113 
We further identified WzzSf-dependent WzySf mutants, and identified a novel role for WzzSf 114 
in WzySf Oag polymerization activity and stability, in addition to its role in regulating Oag 115 
modal chain length.  116 
 117 
Materials and Methods 118 
Bacterial strains and plasmids 119 




Growth media and growth conditions 122 
The growth media used were Luria-Bertani (LB) broth (10 g/liter tryptone, 5 g/liter yeast 123 
extract, 5 g/liter NaCl) and LB agar (LB broth, 15 g/liter bacto agar). 124 
Unless otherwise stated strains were grown in LB broth with aeration for 18 h at 37C, then 125 
diluted 1/20 into fresh LB broth and grown to mid-exponential phase (optical density at 600 126 
nm [OD600] of 0.4 - 0.6). Where required growth medium was supplemented with 0.2% (w/v) 127 
glucose to suppress protein expression. Before induction cells were centrifuged (2200 x g, 128 
SIGMA 3K15 table top centrifuge, 10 min, 4°C) and washed twice with LB broth to remove 129 
glucose. During induction conditions, 0.4 mM isopropyl--D-thiogalactopyranoside (IPTG) 130 
or 0.2% (w/v) or L-arabinose was added to cultures and grown for 20 h at 20C. Antibiotics 131 
were added as required to the media at the following final concentrations: kanamycin (Km; 132 
50 g/ml), and chloramphenicol (Cm; 25 g/ml).  133 
 134 
Construction of expression vector and cloning of wzySf  135 
Primers PN1_wzySfKpnF and PN2_wzySfBamHR (Supplementary Table S1) which 136 
incorporated KpnI and BamHI restriction sites, respectively, were used to amplify the 137 
previously mutated wzySf coding region (GenBank accession number X71970) in the 138 
pRMCD6 plasmid (Table 1), possessing three changes at codons 4, 9 and 23 (18). The rare 139 
codons 4, 9 and 23 are present in the translation initiation site of WzySf and causes lower 140 
expression of the wild-type WzySf. The codons ATA, ATA and AGA at 4, 9 and 23 were 141 
changed to ATT, ATT and CGT, respectively, and resulted in increased expression of WzySf 142 
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(18). Following restriction digestion with enzymes BamHI and KpnI, the amplified wzySf was 143 
ligated into similarly digested pWaldo-TEV-GFP (28), resulting in the plasmid pWaldo-144 
wzySf-TEV-GFP (denoted as pRMPN1). PCR, restriction enzyme digestion, agarose gel 145 
electrophoresis, ligation, and transformation were performed as described previously (3, 146 
14). 147 
  148 
WzySf expression in Lemo21(DE3) and In-gel fluorescence 149 
For WzySf expression in Lemo21(DE3) cells (Table 1), strains were induced with IPTG and 150 
the over-expressed WzySf-GFP fusion protein was detected by In-gel fluorescence following 151 
the method of Drew et al. (2006) (29) with some modifications. 5X108 cells were harvested 152 
from the induced culture and washed twice in 200 µl phosphate buffered-saline (PBS). The 153 
pellet was re-suspended in 20 µl PBS and 20 µl Buffer A (200 mM Tris-HCl [pH 8.8], 20% 154 
[v/v] glycerol, 5 mM EDTA [pH 8.0], 0.02% [w/v] bromophenol blue, 4% [w/v] SDS, and 0.05 155 
M DDT) was then added to the cell suspension. The solubilized cell suspension was 156 
incubated at 37C for 5 min. Samples were then electrophoresed on SDS 15% (w/v) 157 
polyacrylamide gels (SDS-15% PAGE) and BenchMarkTM Pre-Stained Protein Ladder 158 
(Invitrogen) was used as a molecular mass standard. The gel was rinsed with distilled water 159 
and fluorescent imaging of the gel was performed to detect WzySf-GFP protein expression 160 
with a Bio-Rad Gel DocTM XR + System using Image Lab software (excitation at 485 nm 161 




LPS method  164 
LPS was prepared as described previously (30, 31). To prepare LPS samples, 1X109 cells 165 
were harvested and resuspended in lysing buffer (Buffer B - 10% [w/v] glycerol, 2% [w/v] 166 
SDS, 4% [w/v] -mercaptoethanol, 0.1% [w/v] bromophenol blue, 1 M Tris-HCl, pH 7.6) and 167 
incubated with 2 g/ml of proteinase K for approximately 16 h. The LPS samples were then 168 
electrophoresed on a SDS-15% PAGE for 16 to 18 h at 12 mA. The gel was stained with 169 
silver nitrate, developed with formaldehyde (30). 170 
 171 
Random mutagenesis 172 
Random mutagenesis of wzySf was undertaken to obtain a wide range of wzySf mutations in 173 
a non-selected manner. For PCR random mutagenesis the wzySf coding region in plasmid 174 
pRMPN1 was mutagenized by an error prone DNA polymerase using the GeneMorp II EZ- 175 
Clone Domain Mutagenesis Kit (Catalog # 200552, Stratagene) as per the manufacturer’s 176 
instructions with the primers PN1_wzySfKpnF and PN2_wzySfBamHR (Supplementary 177 
Table S1). Mutagenized plasmids were transformed into competent E. coli cells, XL10-Gold 178 
(Agilent Technologies). Plasmid DNA was then isolated from randomly chosen transformed 179 
mutated colonies and transformed into strain PNRM6 (Table 1). Colicin swab assays were 180 
performed to screen the mutants (See below). Plasmid DNA was isolated from putative 181 





Construction of the strain RMA4437 (∆wzy ∆wzz)  185 
The S. flexneri Y PE638 ∆wzy ∆wzz mutant strain was constructed using allelic exchange 186 
mutagenesis (14) to inactivate the wzzSf gene in RMM109 (3). Initially, a tetracycline 187 
resistance (tetR) cartridge was inserted into the BglII site of pRMA577 (14) to inactivate 188 
wzzSf, and the resulting pCACTUS-wzzSf::tet (Table 1) plasmid was transformed into 189 
RMM109 via electroporation (32). Allelic exchange mutagenesis was performed as 190 
previously described (14). The wzzSf::tet
R mutation in the chromosome was confirmed by 191 
PCR with primers ET35 and ET36 (Supplementary Table S1) to give the PE638 ∆wzy ∆wzz 192 
mutant RMA4337. 193 
 194 
Detection of WzySf expression in S. flexneri  195 
For the detection of WzySf expression in S. flexneri, cells were harvested from the 50 ml 196 
0.2% (w/v) L-arabinose induced culture by centrifugation (9800 x g, Beckman J2-21M 197 
Induction Drive Centrifuge, 10 min, 4 °C) and the cell pellet was resuspended in 4 ml 198 
sonication buffer (Buffer C, 20 mM Tris-HCl, 150 mM NaCl, pH 7.5). The mixture was then 199 
lysed by sonication, followed by centrifugation (2200 x g, SIGMA 3K15 table top centrifuge, 200 
10 min, 4 °C) to remove debris. Ultracentrifugation was performed in a Beckman Coulter 201 
Optima L-100 XP bench top ultracentrifuge (126000 x g for 1 h at 4 °C) to isolate the whole 202 
membrane (WM) fraction. The WM fraction was resuspended in PBS and then solubilized in 203 
Buffer A. Solubilized WM fraction from 3 X 108 cells was electrophoresed on a SDS-15% 204 
PAGE. The gel was rinsed with distilled water and In-gel imaging was performed as 205 
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described above. Loading was checked by staining the gel with Coomassie Blue R-250. 206 
The intensity of WzySf-GFP expression for mutant and control strains was measured by Fiji 207 
image processing package (http://fiji.sc/Fiji) and the percent relative WzySf-GFP intensity for 208 
each mutant strain was measured by comparing the WzySf-GFP intensity of each mutant 209 
strain with WzySf-GFP intensity in the control strain PNRM13.  210 
 211 
Colicin sensitivity assay 212 
For the colicin sensitivity assay a solution of purified His6-ColE2 (ColE2) with an initial 213 
concentration of 1 mg/ml was used (11). 214 
 215 
ColE2 swab assay 216 
A two fold serial dilution of 10-3 dilution of ColE2 was swabbed onto antibiotic selective LB 217 
agar plates containing 0.2% (w/v) L-arabinose with a cotton swab. Plates were left to dry for 218 
1 h at room temperature (RT). Individual 0.2% (w/v) L-arabinose induced mutant and 219 
control LB cultures were then swabbed perpendicular to the ColE2 streak and plates were 220 
left to dry for another 1 h at RT. Plates were then incubated for 16 h at 37C. The 221 
susceptibility of the mutant strains compared to the control strain was recorded and the 222 




ColE2 spot assay 225 
The spot assay was performed using the serial dilutions of ColE2. 100 l of the individual L-226 
arabinose induced mutant and control strain cultures were spread onto LB agar plates with 227 
appropriate antibiotics and 0.2% (w/v) L-arabinose. Plates were left to dry for 2 h at RT. A 228 
2-fold serial dilution of 10-3 dilution of ColE2 (denoted as Neat or [N]) was spotted on the 229 
dried plates, and plates were left to dry for another 3 h at RT. Plates were then incubated 230 
for 18 h at 37C. The end point of the killing zones of mutant strains was compared with the 231 
controls. Images were recorded as above.  232 
 233 
Bacteriophage sensitivity assay 234 
Procedures of phage propagation and phage stock preparation have been described 235 
previously (3, 33). The concentration of the bacteriophage Sf6c stock used was 8.6 x 107 236 
p.f.u./ ml. Mutant and control strains were grown and induced with 0.2% (w/v) L-arabinose. 237 
100 l of the individual mutant and control LB cultures were spread onto LB agar plates 238 
with appropriate antibiotics and 0.2% (w/v) L-arabinose. Plates were left to dry for 2 h at RT. 239 
Serial dilutions of the bacteriophage Sf6c stock (undiluted bacteriophage Sf6c stock was 240 
denoted as N) were spotted on the dried plates and plates were dried for a further 3 h at 241 
RT. The plates were incubated for 18 h at 37C. Phage sensitivity of the test strains were 242 





Construction of a WzySf-GFP expression plasmid 246 
A suitable expression system was constructed to express wzySf and to detect WzySf by 247 
fusion to Green Fluorescent Protein (GFP) (29). S. flexneri 2457T 2a wzySf with three 248 
modified codons at postions 4, 9, 23 in pRMCD6 plasmid (18) was PCR amplified and 249 
ligated into pWaldo-TEV-GFP (Table 1) (See Materials and Methods). To confirm the 250 
construct was able to express WzySf-GFP-His8 protein, pWaldo-wzySf-TEV-GFP-His8 251 
(denoted as pRMPN1) was transformed into Lemo21(DE3) cells. Whole cell In-gel 252 
fluorescence samples were then prepared from PNRM15 (Lemo21(DE3), [pRMPN1) and 253 
fluorescent imaging of the gel detected a fluorescent band at approximately 64 kDa which 254 
corresponded to the  predicted size of the WzySf-GFP protein (Supplementary Fig. S1, lane 255 
1), indicating that the construct was able to express WzySf-GFP.  256 
 257 
Complementation of wzySf deficiency 258 
A complementation assay was performed to confirm the functionality of WzySf-GFP. For this 259 
assay pRMPN1 was co-transformed along with pAC/pBADT7-1 (34) into a wzySf deficient 260 
strain RMM109 (3). RMM109 has a frameshift mutation at position 9214 in the wzySf gene 261 
that results in premature termination of WzySf synthesis (3). pAC/pBADT7-1 encodes T7 262 
RNA polymerase which drives the expression of wzySf-GFP in pRMPN1. LPS samples were 263 
prepared from these control strains. The silver-stained gel showed that PNRM6 (RMM109, 264 
pAC/pBADT7-1) had a SR-LPS profile (Fig. 1, lane 3). But the PNRM13 (PNRM6, 265 
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pRMPN1) had a S-LPS profile (Fig. 1, lane 5). Hence, pRMPN1 was able to complement 266 
the wzySf mutation in RMM109, and the LPS profile resembled that of the wild type strain 267 
PE638 (Fig. 1, lane 2).  268 
 269 
Random mutagenesis of wzySf  270 
Nothing is known about the residues important for WzySf function, and there is little 271 
sequence identity between Wzy proteins of different bacterial species. Hence, it is difficult 272 
to predict the functional amino acid residues of the S. flexneri WzySf. To obtain insight into 273 
the WzySf residues needed for function, wzySf coding region in plasmid pRMPN1 was 274 
subjected to random mutagenesis using an error prone DNA polymerase (See Materials 275 
and Methods). The resulting mutagenized plasmid library was transformed into PNRM6. We 276 
screened the transformants to find mutants using ColE2. The basis for this is that the R-277 
LPS strains are more susceptible to the killing by colicins than the S-LPS strains (12), and 278 
we recently found that there is a strong correlation between LPS Oag modal chain length 279 
and susceptibility to ColE2 (11). A ColE2 swab assay (See Materials and Methods) was 280 
used to screen and detect mutants that had a different sensitivity to ColE2 compared to the 281 
positive control strain PNRM13 (Supplementary Table S2). Interestingly the wild type strain 282 
PE638 was slightly more resistant to ColE2 compared to the complemented positive control 283 
strain PNRM13 (Supplementary Table S2) (Table 2). The wzySf mutant RMM109 (SR-LPS) 284 
was highly sensitive to ColE2 (Supplementary Table S2) (Table 2). Transformants that were 285 
either more resistant or more sensitive to ColE2 than PNRM13 were selected 286 
(Supplementary Table S2), and the plasmids isolated and transformed into the XL10G 287 
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strain. Plasmid DNA from these isolates was subjected to DNA sequencing to identify 288 
mutational alterations in wzySf. The wzySf mutants had the following substitutions: P352H, 289 
V92M, Y137H, L214I, G130V, N147K, P165S, L191F, C60F, L49F/T328A, L28V, N86K, 290 
F54C, F52Y, L111I, G82C, and F52C/I242T (Supplementary Table S3). The mutations 291 
were present in PL1, 2, 3, and 6; TM 2, 4, 5, 7, 8, and 9; and Cytoplasmic Loops (CL) 1 and 292 
5 of the WzySf topology map (summarized in Fig. 2 and Table 2). After sequence 293 
confirmation, the mutated plasmids were transformed into PNRM6 (Table 1) for detailed 294 
characterization. 295 
 296 
LPS phenotype conferred by WzySf mutants 297 
The effect of mutations on WzySf LPS Oag polymerization activity was determined by SDS-298 
PAGE and silver staining. Following comparison of the resulting degree of LPS Oag 299 
polymerization of the mutant strains with the relevant positive control PNRM13, the mutants 300 
were grouped into four different phenotypic classes: A, B, C, and D (Fig. 3 and 301 
Supplementary Fig. S2). Three of the 17 mutants had reduced degrees of polymerization 302 
compared to PNRM13 and were classified as class A. Class A mutants had following 303 
alterations in WzySf: P352H, V92M, Y137H (Fig. 3, lanes 2-4). One mutant (with L214I 304 
alteration in WzySf) exhibited LPS banding pattern with only a few Oag RUs and was 305 
classified as Class B   (Fig. 3, lane 5). Another mutant had SR-LPS (with a G130V alteration 306 
in WzySf) and was categorized into Class C (Fig. 3, lane 6). The other 12 mutants conferred 307 
a LPS profile nearly similar to the positive control PNRM13 and were classified as Class D. 308 
Members of this class had the following mutations: N147K, P165S, L191F, C60F, 309 
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L49F/T328A, L28V, N86K, F54C, F52Y, L111I, G82C, F52C/I242T (Fig. 3, lanes 7-10 and 310 
Supplementary Fig. S2, Lanes 1-8). For rest of the paper the mutant WzySf proteins will be 311 
referred according to their conferred LPS class. 312 
 313 
WzzSf dependence 314 
Since the Wzy-dependent model of LPS assembly suggests a potential interaction between 315 
Wzy and Wzz, we investigated if the LPS profile conferred by mutated WzySf proteins was 316 
dependent on the presence of WzzSf. All the plasmids encoding mutated WzySf proteins 317 
were transformed into RMA4337 carrying pAC/pBADT7-1 (strain PNRM126) (Table 1). 318 
RMA4337 is a wzySf and wzzSf double mutant. The LPS profiles conferred in the PNRM126 319 
background (∆wzy ∆wzz) were directly compared with the LPS profile conferred in the ∆wzy 320 
background (PNRM6). The control strain PNRM134 (PNRM126 [pRMPN1]) had S-LPS 321 
without Oag modal chain length control (Fig. 4, lane 3) as expected, and was classified as 322 
Class E for the purpose of comparison. PNRM126 with mutated wzySf plasmids that 323 
conferred a Class A LPS profile in the ∆wzy background had a Class E LPS profile similar 324 
to PNRM134, except PNRM126 expressing WzyP352H had LPS with few Oag RUs (Class 325 
B) (Fig. 4, lane 5). PNRM126 expressing WzyL214I had SR-LPS (Fig. 4, lane 11). 326 
However, in comparison PNRM6 (∆wzy) expressing WzyL214I conferred a Class B LPS 327 
profile (Fig. 4, lane 10). PNRM126 with a mutated wzySf plasmid that conferred a Class C 328 
LPS profile in the ∆wzy background (PNRM6 expressing G130V), had S-LPS without modal 329 
length control and a reduced degree of polymerization (designated Class F) compared to 330 
PNRM134 (Fig. 4, lane 13). PNRM126 with mutated wzySf plasmids from the strains with 331 
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Class D LPS profile in the ∆wzy background, had Class E LPS profile, similar to PNRM134 332 
(Fig. 4, lanes 14-21 and Supplementary Fig. S3, lanes 1-16). Hence certain WzySf mutants 333 
conferred dramatically different LPS profiles depending on the presence and absence of 334 
WzzSf. 335 
 336 
ColE2 and bacteriophage Sf6c sensitivities  337 
To confirm the LPS profiles determined above using assays of LPS Oag function, the ColE2 338 
and bacteriophage Sf6c sensitivities of the mutant strains were investigated. ColE2 339 
sensitivity (summarized in Table 2) was determined by spot testing as described in the 340 
Materials and Methods. Strains RMM109, PNRM6, PNRM11, RMA4337, and PNRM126 341 
showed killing zones at a dilution of 1/256. The wild type strain PE638 was resistant to the 342 
highest concentration of ColE2 used. The relevant positive control strain in the ∆wzy 343 
background (PNRM13) showed a killing zone at a dilution of 1/2 but the relevant positive 344 
control strain in the ∆wzy ∆wzz background (PNRM134) was resistant to the tested highest 345 
concentration of ColE2. Strains conferring Class A LPS profile in the ∆wzy background 346 
were sensitive to ColE2 (killing zone at 1/32 or 1/64). However, ∆wzy ∆wzz strains with 347 
mutated wzySf plasmids conferring the Class A LPS profile in the ∆wzy background were 348 
two-fold more sensitive to ColE2 (killing zone at 1/64 or 1/128) compared to the ∆wzy 349 
background. The ∆wzy strain expressing WzyL214I (Class B) and the ∆wzy ∆wzz strain 350 
expressing WzyL214I (Class C) had similar ColE2 sensitivity (1/128). The strain with the 351 
Class C LPS profile (∆wzy expressing WzyG130V) had the greatest sensitivity to ColE2 352 
(1/512), greater than RMM109 and the negative control strains (PNRM6, PNRM11, 353 
  
18 
PNRM126). However, the ∆wzy ∆wzz strain expressing WzyG130V (Class F) was more 354 
resistant (1/128) to ColE2 compared to the ∆wzy background. Strains with Class D LPS 355 
profile in the ∆wzy background were resistant to the tested highest concentration of ColE2, 356 
except ∆wzy expressing WzyP165S showed slight sensitivity (1/4). Hence, almost all the 357 
strains with Class D LPS profile in the ∆wzy background were more resistant to ColE2 358 
compared to PNRM13 and were similar to PE638. The ∆wzy ∆wzz strains with mutated 359 
wzySf plasmids from the strains with Class D LPS profile in the ∆wzy background were 360 
more sensitive to ColE2 (killing zone at 1/8 to 1/64) compared to the control PNRM134 361 
(∆wzy ∆wzz [pRMPN1]), suggesting they have slight defect in Oag polymerization in the 362 
absence of WzzSf. Hence, ColE2 resistance correlated with degree of Oag polymerization 363 
and degree of LPS capping with Oag.  364 
        365 
The bacteriophage Sf6c sensitivity of the strains (summarized in Table 2), carrying mutated 366 
wzySf plasmids, was determined by spot testing as described in the Materials and Methods. 367 
The SR-LPS strains RMM109, PNRM6, PNRM11, RMA4337, and PNRM126 were resistant 368 
to bacteriophage Sf6c. The S-LPS strains wild type PE638, and the controls PNRM13 and 369 
PNRM134 were bacteriophage Sf6c sensitive, and plaques were detected at 10-6, 10-5, and 370 
10-6 dilutions, respectively. Strains with Class A, B, and C LPS profiles in the ∆wzy 371 
background were resistant to the highest concentration of bacteriophage Sf6c tested and 372 
were similar to the strains with SR-LPS (RMM109, PNRM6, PNRM11, RMA4337, and 373 
PNRM126). Similarly, the ∆wzy ∆wzz strains with mutated wzySf plasmids from the strains 374 
with Class A, B, and C LPS profiles in the ∆wzy background were also resistant to the 375 
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highest concentration of bacteriophage Sf6c tested. Strains with Class D LPS profile in the 376 
∆wzy background were bacteriophage Sf6c sensitive (plaques at 10-6), except for the strain 377 
expressing WzyP165S was slightly less sensitive (plaque at 10-5). Hence, the 378 
bacteriophage Sf6c sensitivity of the strains with Class D LPS profile in the ∆wzy 379 
background was greater than PNRM13 and similar to PE638. ∆wzy ∆wzz strains with 380 
mutated wzySf plasmids from the strains with Class D LPS profile in the ∆wzy background 381 
were more resistant to bacteriophage Sf6c compared to the ∆wzy background. Although 382 
they have a Class E LPS profile, similar to PNRM134, they were more resistant to 383 
bacteriophage Sf6c than PNRM134. Hence, bacteriophage Sf6c correlated with degree of 384 
Oag polymerization, and degree of LPS capping with Oag.  385 
 386 
WzySf expression level  387 
We determined the level of parental and mutant WzySf-GFP expressed in ∆wzy and ∆wzy 388 
∆wzz S. flexneri strains. To measure the protein expression level of the mutants, In-gel 389 
fluorescence was performed and the % relative WzySf-GFP expression was calculated (See 390 
Materials and Methods). The expression levels of different WzySf-GFP mutants were 391 
compared with that of WzySf-GFP in PNRM13 (100%). The WzySf-GFP expression level in 392 
PNRM134 was less than PNRM13 (Fig. 5A and B, lane 2), having a relative WzySf-GFP 393 
level of 17% (Table 2). In the ∆wzy background most of the WzySf-GFP mutants were 394 
expressed at a level less than 100% except the mutants L191F (Class D) had expression of 395 
162% (Fig. 5B, lane 7 and Table 2). However, in the ∆wzy ∆wzz background the relative 396 
WzySf-GFP level of L191F was 64% (Fig. 5B, lane 8 and Table 2), which was less than the 397 
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control PNRM13. In the ∆wzy background, the relative WzySf-GFP levels of P165S, L214I, 398 
and G130V were very low (7%, 1.4%, and 1.6% respectively) (Fig. 5B, lane 5; Fig. 5A, 399 
lanes 9 and 11; and Table 2). However, in the ∆wzy ∆wzz background P165S and G130V 400 
had relative WzySf-GFP levels of 125% and 28.50%, respectively (Fig. 5B, lane 6; Fig 5A, 401 
lane 12; and Table 2) but the relative WzySf-GFP level of L214I was almost not detectable 402 
at 0.03% (Fig. 5A, lane 10 and Table 2). In the ∆wzy ∆wzz background, the relative WzySf-403 
GFP level of P165S was higher than the control PNRM13 (100%) (Fig. 5B, lane 6 and 404 
Table 2). These data indicates that expression of certain WzySf mutants were affected by 405 
WzzSf, but the effect was mutant specific. 406 
 407 
Discussion 408 
In this study, we constructed and characterized a collection of wzySf mutants. We found that 409 
ColE2 screening was an effective method to detect wzySf mutants conferring subtle effects 410 
on LPS structure (Table 2). The use of WzySf-GFP allowed comparison of the protein 411 
expression level of different mutants. We also found that bacteriophage Sf6c sensitivity was 412 
dependent on LPS phenotype structure. Strains with mutant WzySf conferring longer Oag 413 
chain and/or a greater degree of Oag polymerization were more sensitive to bacteriophage 414 
Sf6c; while bacteriophage Sf6c only infected strains with wild type (or nearly wild type) LPS, 415 




Only a few studies have been conducted on Wzy proteins. During characterization of Wzy 418 
of Francisella tularensis, Kim et al. (2010) reported several amino acid residues important 419 
for Oag polymerization. Modification of these residues (G176, D177, G323, and Y324) led 420 
to a loss of Oag polymerization (35). Islam et al. showed that the PL3 and PL5 of WzyPa 421 
have net positive and net negative charges respectively and they established their “catch-422 
and-release” model (20). However, for WzySf, we found that at a physiological pH both the 423 
PL3 and PL5 possess net negative charge (pI of PL3 is 4.65 and PL5 is 5.09). In 424 
Pseudomonas aeruginosa PAO1 there is a uronic acid sugar in the Oag (36), which is 425 
negatively charged. However, the Oag of WzySf is neutral. So, the charged property of the 426 
substrate for WzySf is different from the WzyPa.The RX10G motifs of the PL3 and PL5 of 427 
WzyPa (20) are also absent in WzySf. However, both PL3 and PL5 of WzySf contained RX15G 428 
motifs (starting from R164 in PL3 and R289 in PL5) (Fig. 2). So, perhaps a modified version 429 
of the “catch-and-release” mechanism (20) exists for S. flexneri. Moreover, addition of 430 
either glucosyl or O-acetyl groups or PEtN residue by various linkages to the sugars within 431 
the tetrasaccharide repeats of serotype Y creates 17 different serotypes of the S. flexneri 432 
(5-7). As the polymerization of all these Oags is done by WzySf, and we conclude that WzySf 433 
must be quite flexible for its substrate recruitment. Due to scant homology between wzy 434 
proteins of different bacterial species, we were unable to create any directly comparable 435 
mutation in WzySf with respect to other systems. This led us to perform random 436 




The mutations we found are present in a wide region (PL1, 2, 3, 5, and 6; TM 2, 4, 5, 7, 8, 439 
and 9; and CL 1 and 5) of the WzySf topological model experimentally determined by 440 
Daniels et al. (1998) (18). We were able to locate a number of mutations in the TM regions 441 
and interestingly the G130V mutation, which resulted in the complete loss of polymerization 442 
activity of WzySf in the ∆wzy background, was also located in TM5. Topological models are 443 
not very accurate but due to a lack of crystal structure we used the WzySf topology model 444 
previously determined by our group to locate the mutational alterations. Furthermore, we 445 
reassessed our topological model using 5 different topology prediction programs 446 
(SPOCTOPUS, MEMSAT, HMMTOP, TOPCONS, and TMHMM) (Supplementary Table 447 
S4). The results showed that until trans-membrane (TM) region 6 all the programs are 448 
consistent with our topological model. Three of them also validate TM10 - TM11 of our 449 
topological model. So, the topological model of WzySf determined by our group is nearly 450 
consistent with the topological models predicted by the programs. The mutations, which 451 
resulted in the partial loss of polymerization in the ∆wzy background, were V92M, Y137H, 452 
L214I, and P352H. Among them V92M and Y137H are present in the PL2 and TM5. These 453 
regions were validated by 5 of the programs. P352H is present in the PL6 and this region 454 
was validated by 3 of the programs (MEMSAT, HMMTOP, and TOPCONS). L214I is 455 
present in the TM8 and this region (amino acid 209 - 226) was different compared to the 456 
computer prediction (amino acid 227 - 247). However, G130V is present in the TM5, which 457 
was validated by 5 of the programs. Recently, Reddy et al. (2014) reported that different 458 
topology prediction programs are suitable for different families of proteins (37). So, non-459 
prediction of TM7 - TM9 by some programs does not invalidate the presence of these 460 
regions in our model.   461 
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In the ∆wzy background, strains with the Class A LPS profile had S-LPS with reduced 462 
degree of Oag polymerization (Fig. 3, lanes 2-4), mutants with the Class B LPS profile had 463 
LPS with few Oag RUs (Fig. 3, lane 5), and the mutant with Class C LPS profile had SR-464 
LPS (Fig. 3, lane 6). As a result the Class A mutants were more sensitive to ColE2 than 465 
PNRM13 and the Class B mutants were even more sensitive to ColE2 than the mutants 466 
with the Class A LPS profile. The mutant with Class C LPS had the highest ColE2 467 
sensitivity. From these three classes it is clear that the LPS with shorter Oag chains were 468 
more sensitive to ColE2. Strains with Class A, B, and C LPS profiles in the ∆wzy 469 
background were resistant to bacteriophage Sf6c. The lack of bacteriophage Sf6c 470 
sensitivity indicates that bacteriophage Sf6c only infects if the LPS has wild type or close to 471 
wild type level of Oag polymerization. In this study we found that the WzySf mutants 472 
conferring the Class D LPS profile in the ∆wzy background, had a similar level of Oag 473 
polymerization compared to the positive control strain PNRM13, as determined by SDS-474 
PAGE and silver staining (Fig. 3, lanes 7-10 and Supplementary Fig. S2, lanes 1-8) but 475 
they were more resistant to ColE2 and more sensitive to bacteriophage Sf6c (Table 2) 476 
(except ∆wzy strain with WzyP165S). The ColE2 and bacteriophage Sf6c sensitivities of 477 
these strains were similar to wild type strain PE638. We conclude that the Oag 478 
polymerization activity of the mutants with Class D LPS profile in the ∆wzy background, was 479 
similar to the wild type strain (PE638). Hence, the wild type WzySf-GFP protein is not 100% 480 
active, and the mutant proteins conferring the Class D LPS profile are more active and/or 481 
are better exported or folded or assembled to the IM. The level of Oag polymerization of the 482 
strains with Class D LPS profile was more than PNRM13, although this was not 483 
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distinguishable by silver staining. Hence, the ColE2 assay was more sensitive than silver 484 
staining and SDS-PAGE in determining the degree of Oag polymerization.  485 
 486 
Mutation in wzz resulted in Oag without modal chain length control in different organisms 487 
(14, 24). Recently, Kenyon and Reeves showed that Wzy of Yersinia pseudotuberculosis 488 
also needs Wzz for complete Oag polymerization (38). Here we examined the 489 
polymerization activity of different WzySf mutants in the absence of WzzSf. In the ∆wzy ∆wzz 490 
background, the strains with mutated wzySf plasmids from the strains having Class B LPS 491 
profiles in the ∆wzy background had a SR-LPS profile, and ColE2 and bacteriophage Sf6c 492 
sensitivities were similar to the ∆wzy background. Interestingly, the ∆wzy ∆wzz strain with 493 
WzyG130V had S-LPS without modal length control (Class F) where as the ∆wzy strain 494 
with WzyG130V had SR-LPS (Class C) and this correlated with an increased resistance to 495 
ColE2. In the ∆wzy ∆wzz background, strains with a Class E LPS profile (S-LPS without 496 
modal length control) had increased sensitivity to ColE2 and increased or similar resistance 497 
to bacteriophage Sf6c compared to PNRM134 (∆wzy ∆wzz [pRMPN1]) and when in the 498 
∆wzy background (strains with Class A and Class D LPS profiles) (Table 2). We speculate 499 
that these strains (strains with a Class E LPS profile) had subtle alterations in the level of 500 
Oag polymerization and/or capping of LPS with Oag, and were unable to act efficiently as a 501 
bacteriophage Sf6c receptor, and correspondingly were also more sensitive to ColE2. It is 502 
known that phage adsorption to the cells of Escherichia coli K12 increases with increase in 503 
density of receptor protein at the cell surface (39). Based on our study, the relationship 504 
between ColE2 and Oag density/concentration seems linear. Deceasing Oag progressively 505 
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increases sensitivity to ColE2. However, the relationship between bacteriophage Sf6c and 506 
Oag density/concentration seems non-linear. Decreasing Oag rapidly decreases sensitivity 507 
to bacteriophage Sf6c. This may be because bacteriophage Sf6c interaction with its 508 
receptor is complex and most likely requires multi-receptor binding to bacteriophage Sf6c 509 
tail spike proteins (TSPs) to achieve irreversible binding and hence activation of 510 
bacteriophage Sf6c. 511 
 512 
According to the proposed molecular clock model, Wzz acts as a molecular clock and 513 
regulates Wzy activity between two states: “E” or extension state favors polymerization and 514 
“T” or transfer state favors the ligation reaction (24). The molecular chaperone model 515 
describes Wzz as a typical molecular chaperone, which regulates the overall ratio of Wzy 516 
and WaaL in a complex, and controls the enzyme kinetics of the ligation reaction to define 517 
the modality (14). However, Woodward et al. (2010) suggests that there is an interaction 518 
between Wzy and Wzz and they showed that these proteins are enough to shape the Oag 519 
modal chain length (26). Islam et al. (2013) suggested that the chain length of the Oag is 520 
determined by the interaction of Wzz and Wzy (40). Recent work of Taylor et al. (2013) also 521 
suggested the direct interaction of Wzz and Wzy in the Oag biosynthesis pathway (41). In 522 
this study, for the first time we were able to give an insight in the association of WzySf and 523 
WzzSf in the Oag biosynthesis. We found WzySf mutants where polymerization activity was 524 
dependent on WzzSf (WzyP352H and WzyL214I), and some other mutants where 525 
polymerization activity was repressed in the presence of WzzSf (WzyV92M, WzyY137H, and 526 
WzyG130V). The Δwzy Δwzz strain with WzyV92M or WzyY137H had S-LPS without 527 
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modal length control (Class E) but in the Δwzy background, they showed Class A LPS 528 
profile (a greatly reduced degree of Oag polymerization) (Fig 4, lanes 6-7 and lanes 8-9). 529 
The Δwzy strain with WzyG130V had Class C LPS profile (SR-LPS) but remarkably the 530 
Δwzy Δwzz strain with WzyG130V had S-LPS without modal length control albeit with a 531 
reduced degree of polymerization (Class F) (Fig 4 lanes 12-13). Oag polymerization by 532 
these WzySf mutants was repressed by WzzSf, in the ΔwzySf background; their LPS had 533 
shorter Oag chains. The Δwzy strain with WzyP352H had Class A LPS profile, and the 534 
Δwzy strain with WzyL214I had Class B LPS profile but in the Δwzy/Δwzy background they 535 
had shorter Oag chains (Class B and C respectively) compared to the Δwzy background 536 
(Fig. 4, lanes 4-5 and 4 lanes 10-11). So, these WzySf mutants need WzzSf for their Oag 537 
polymerization activity. These findings suggest that WzzSf is associated with WzySf not only 538 
for Oag modal chain length control but also for polymerization activity, and amino acids 539 
V92, G130, Y137, L214, and P352 have role in the association of WzySf and WzzSf during 540 
the Oag polymerization mediated by WzySf.   541 
 542 
The relative WzySf-GFP level in PNRM134 (Δwzy Δwzz) was lower than in PNRM13 (Δwzy) 543 
(Fig. 5A and B, lanes 1-2), suggesting that the wild type WzySf-GFP had better expression 544 
in the presence of WzzSf. WzySf mutants conferring Class A LPS profile (Δwzy background) 545 
had WzySf-GFP levels less than the WzySf-GFP in PNRM13 (Fig. 5A, lanes 3, 5, 7 and 546 
Table 2). WzyL214I was not detectable either in the Δwzy (Class B) or Δwzy Δwzz (Class 547 
C) backgrounds (Fig. 5A, lanes 9-10 and Table 2). Hence, amino acid L214 is important for 548 
WzySf-GFP production. WzyG130V was not detectable in the Δwzy background (Class C) 549 
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but was detected in the Δwzy Δwzz background (Class F) (Fig. 5A, lanes 11-12 and Table 550 
2). Except for the strain Δwzy with WzyL191F, all the mutants with Class D LPS profile 551 
(Δwzy background) had a lower protein expression level than WzySf-GFP in PNRM13 (Fig. 552 
5B and Table 2) by some unknown mechanism. However, the mutants with Class D LPS 553 
profile (Δwzy background) had S-LPS and were more resistant to ColE2 and more sensitive 554 
to bacteriophage Sf6c than PNRM13. In the Δwzy Δwzz background WzyL191F had an 555 
expression level less than WzySf-GFP in PNRM13 (Fig. 5B, lane 8 and Table 2). WzyP165S 556 
was not detectable in PNRM6 (Δwzy) but strain PNRM126 (Δwzy Δwzz) with WzyP165S 557 
present at a greater level than WzySf-GFP in PNRM13 (Fig. 5B, lanes 5-6 and Table 2). 558 
Apparently there are more than one underlying mechanism for the Class D (Δwzy 559 
background) to Class E (Δwzy Δwzz background) LPS profile conversion. Some of the 560 
mutations (P165S and G130V) resulted in decreased WzySf-GFP levels in the presence of 561 
WzzSf. This suggested that the presence of WzzSf destabilizes WzyP165S and WzyG130V, 562 
which resulted in lower WzySf-GFP levels. The mutation L191F resulted in decreased 563 
WzySf-GFP level in the absence of WzzSf. So, in this case WzzSf stabilizes the protein 564 
WzyL191F resulting in better WzySf-GFP expression. This finding suggests that G130, 565 
P165, and L191 are important for the stabilization of WzySf through interaction with WzzSf.  566 
 567 
In conclusion, our findings identified amino acid residues on the WzySf important for its 568 
polymerization function and interaction with WzzSf. Residues, which are important for the 569 
polymerization and interaction of WzzSf and WzySf are present in the PL 2, 6 and TM 5, 8. 570 
These regions may contribute in the interaction of WzySf with substrates and also in the 571 
  
28 
interaction with WzzSf. We identified a number of amino acids (G130, P165, L191), which 572 
are important for the stabilization of WzySf in association with WzzSf. Hence, our data 573 
suggested that WzzSf also has a role in WzySf stability.  574 
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Table 1. Bacterial strains and plasmids used in this study 704 
Strains or Plasmids Characteristics Reference 
S. flexneri Strains   
PE638 S. flexneri Y rpoB (RifR) (14) 
RMM109 PE638Δwzy, RifR (3) 
RMA4337 RMM109 Δwzz (RifR, TetR) This study 
PNRM6 RMM109 [pAC/pBADT7-1] This study 
PNRM11 PNRM6 [pWaldo-TEV-GFP] This study 
PNRM13 PNRM6 [pRMPN1] This study 
PNRM75 PNRM6 [pRMPN7] This study 
PNRM76 PNRM6 [pRMPN8] This study 
PNRM77 PNRM6 [pRMPN9] This study 
PNRM78 PNRM6 [pRMPN10] This study 
PNRM79 PNRM6 [pRMPN11] This study 
PNRM80 PNRM6 [pRMPN12] This study 
PNRM81 PNRM6 [pRMPN13] This study 
PNRM82 PNRM6 [pRMPN14] This study 
PNRM83 PNRM6 [pRMPN15] This study 
PNRM84 PNRM6 [pRMPN16] This study 
PNRM85 PNRM6 [pRMPN17] This study 
PNRM119 PNRM6 [pRMPN19] This study 
PNRM120 PNRM6 [pRMPN21] This study 
PNRM121 PNRM6 [pRMPN22] This study 
PNRM122 PNRM6 [pRMPN23] This study 
PNRM123 PNRM6 [pRMPN24] This study 
PNRM124 PNRM6 [pRMPN25] This study 
PNRM126 RMA4337 [pAC/pBADT7-1] This study 
PNRM134 PNRM126 [pRMPN1] This study 
PNRM131 PNRM126 [pRMPN7] This study 
PNRM132 PNRM126 [pRMPN15] This study 
PNRM133 PNRM126 [pRMPN16] This study 
PNRM136 PNRM126 [pRMPN8]  This study 
PNRM137 PNRM126 [pRMPN10]  This study 
PNRM140 PNRM126 [pRMPN13]  This study 
PNRM141 PNRM126 [pRMPN14]  This study 
PNRM142 PNRM126 [pRMPN9]  This study 
PNRM143 PNRM126 [pRMPN11]  This study 
PNRM144 PNRM126 [pRMPN19]  This study 
PNRM145 PNRM126 [pRMPN24] This study 
PNRM146 PNRM126 [pRMPN25] This study 
PNRM147 PNRM126 [pRMPN23] This study 
PNRM148 PNRM126 [pRMPN21] This study 
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Table 1: cont.   
Strains or Plasmids Characteristics Reference 
S. flexneri Strains   
PNRM149 PNRM126 [pRMPN22] This study 
PNRM150 PNRM126 [pRMPN12] This study 
PNRM151 PNRM126 [pRMPN17] This study 





endA1 supE44 thi-1 recA1 gyrA96 relA1 lac  





fhuA2 [lon] ompT gal [λ DE3] [dcm] ∆hsdS/ 
pLemo[CamR] λ DE3 = λ sBamHIo ∆EcoRI-
B int:: [lacI :: PlacUV5 ::T7 gene1] i21 ∆nin5 
pLemo = pACYC184-PrhaBAD-lysY 
New England 
Biolabs 
PNRM15 Lemo21(DE3) [pRMPN1] This study 
Plasmids   
pRMCD6 Source of wzySf [modified codons at 
positions 4, 9, and 23]. 
(18) 
pAC/pBADT7-1 Source of T7 RNA polymerase; CmR (34) 
pWaldo-TEV-GFP Cloning vector with GFP tag; KmR (28) 
pRMPN1 pWaldo-wzySf-GFP; Km
R This study 
pRMPN7 pRMPN1 with G130V point mutation in the 
wzySf gene 
This study 
pRMPN8 pRMPN1 with L111I point mutation in the 
wzySf gene 
This study 
pRMPN9 pRMPN1 with N86K point mutation in the 
wzySf gene 
This study 
pRMPN10 pRMPN1 with L28V point mutation in the 
wzySf gene 
This study 
pRMPN11 pRMPN1 with P165S point mutation in the 
wzySf gene 
This study 
pRMPN12 pRMPN1 with G82C point mutation in the 
wzySf gene 
This study 
pRMPN13 pRMPN1 with N147K point mutation in the 
wzySf gene 
This study 
pRMPN14 pRMPN1 with L191F point mutation in the 
wzySf gene 
This study 
pRMPN15 pRMPN1 with L214I point mutation in the 
wzySf gene 
This study 
pRMPN16 pRMPN1 with P352H point mutation in the 
wzySf gene 
This study 
pRMPN17 pRMPN1 with V92M point mutation in the 
wzySf gene 
This study 
pRMPN19 pRMPN1 with F52Y point mutation in the 
wzySf gene 
This study 
pRMPN21 pRMPN1 with F52C/I242T point mutations This study 
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in the wzySf gene 
Table 1: cont.   
Strains or Plasmids Characteristics Reference 
Plasmids   
pRMPN22 
 
pRMPN1 with C60F point mutation in the 
wzySf gene 
This study 
pRMPN23 pRMPN1 with Y137H point mutation in the 
wzySf gene 
This study 
pRMPN24 pRMPN1 with L49F/T328A point mutation in 
the wzySf gene 
This study 
pRMPN25 pRMPN1 with F54C point mutation in the 
wzySf gene 
This study 
pCACTUS Suicide vector containing sacB, CmR, and 
Orits 
(14) 
pRMA577 Suicide vector contatining SphI-SphI 




R Suicide mutagenesis construct to construct 
the strain RMA4337 
This study 
 705 












Table 2. ColE2 sensitivity, Sf6c sensitivity, and WzySf-GFP expression of the controls and different classes of mutants. 716 


















RMM109 wzySf mutants 1/256 - R - - - 
PE638 Wild type R - 10
-6 - 
- - 
PNRM13 Positive control 1/2 - 10
-5 - 
100% - 
PNRM6 Negative control 1/256 - R - - - 
PNRM11 Negative control 1/256 - R - - - 
RMA4337 wzySf and wzySf mutant - 1/256 - R
 
- - 
PNRM126 Negative control - 1/256 - R - - 
PNRM134 Positive control - R - 10
-6 
- 17% 































P352H Class A Class B PL6 1/64 1/128 R R 36% 38% 
V92M Class A Class E PL2 1/32 1/64 R R 84% 76% 
Y137H Class A Class E TM5 1/32 1/64 R R 87% 97% 
L214I Class B Class C TM8 1/128 1/128 R R 1.4% 0.03% 
G130V Class C Class F TM5 1/512 1/128 R R 1.60% 28.50% 
N147K Class D Class E PL3 R 1/16 10
-6
 R 21% 52% 
P165S Class D Class E PL3 1/4 1/64 10
-5 
N 7% 125% 
L191F Class D Class E TM7 R 1/16 10
-6
 N 162% 64% 
C60F Class D Class E TM1 R 1/64 10
-6
 N 30% 66% 
L49F/T328A Class D  Class E TM2/CL5 R 1/64 10
-6
 R 65% 68% 





N86K Class D Class E PL2 R 1/64 10
-6
 R 84% 82% 
F54C Class D Class E CL1 R 1/64 10
-6
 R 42% 71% 
F52Y Class D Class E TM2 R 1/64 10
-6
 R 47% 63% 
L111I Class D Class E TM4 R 1/8 10
-6
 N 41% 51% 
G82C Class D Class E PL2 R 1/64 10
-6
 R 40% 47% 
F52C/I242T Class D Class E TM2/TM9 R 1/64 10
-6
 N 82% 81% 
 717 





Fig. 1. Complementation of wzySf deficiency by WzySf-GFP 721 
LPS samples (equivalent to 1 × 109 bacterial cells) were prepared from the strains indicated 722 
in the figure by proteinase K treatment, electrophoresed on a SDS-15% (w/v) PAGE gel, 723 
and silver stained (See Materials and Methods). Strains in each lane are as follows: 1. 724 
  
2 
RMM109, 2. PE638, 3. PNRM6 (RMM109 [pAC/pBADT7-1]), 4. PNRM6 [pWaldo-TEV-725 
GFP], 5. PNRM13 (PNRM6 [pRMPN1]). Positions of S-LPS, SR-LPS, and R-LPS are 726 











Fig. 2. Location of the mutations on the topology map of WzySf.  736 
Mutational alterations were indicated by arrows on the WzySf topology map (adapted from 737 
Daniels et al. 1998). The position of the periplasmic loops (PL) 1-5, transmembrane regions 738 
(TM) 1-12, cytoplasmic loops (CL) 1-5, and inner membrane (IM) are indicated. Mutations 739 







Fig. 3. LPS phenotype conferred by different WzySf mutants expressed in PNRM6 745 
(∆wzySf, [pAC/pBADT7-1]). 746 
Plasmid encoded mutated WzySf proteins were expressed in PNRM6. Strains were grown 747 
and induced with arabinose as described in the Materials and Methods. LPS samples were 748 
prepared, electrophoresed on a SDS-15% (w/v) PAGE gel, and silver stained (See 749 
  
5 
Materials and Methods). Strains were divided into various mutant Classes (A, B, C, and D) 750 
based on their LPS phenotype.  751 
Lane 1, the positive control strain PNRM13 (PNRM6 [pRMPN1]). Lanes 2-18 are the ∆wzy 752 
strain (PNRM6) with plasmids encoding mutated WzySf protein. The WzySf mutants in each 753 
lane are: 2. P352H (Class A), 3.V92M (Class A), 4. Y137H (Class A), 5. L214I (Class B), 6. 754 
G130V (Class C), 7. N147K (Class D), 8. P165S (Class D), 9. L191F (Class D), 10. C60F 755 









Fig. 4. Comparison of the LPS phenotype conferred by the WzySf mutants expressed 763 
in the ∆wzy and ∆wzy ∆wzz backgrounds.  764 
Plasmids encoding mutated WzySf proteins were expressed in PNRM126 (RMA4337 765 
[pAC/pBADT7-1]) and PNRM6 (RMM109 [pAC/pBADT7-1]). Strains were grown and 766 
  
7 
induced as described in the Materials and Methods. LPS samples were electrophoresed on 767 
a SDS-15% (w/v) PAGE gel and silver stained (See Materials and Methods).  768 
Lanes 1-3 are: 1. PNRM13, and 2. PNRM126, and 3. PNRM134 (PNRM126 [pRMPN1]). 769 
Lanes 4-36 are the Δwzy (PNRM6) or Δwzy Δwzz (PNRM126) strains with plasmids 770 
encoding mutated WzySf protein. The WzySF mutants in each lane are as follows: 4. P352H 771 
(Δwzy), 5. P352H (Δwzy Δwzz), 6. V92M (Δwzy), 7. V92M (Δwzy Δwzz), 8. Y137H (Δwzy), 772 
9. Y137H (Δwzy Δwzz), 10. L214I (Δwzy), 11. L214I (Δwzy Δwzz), 12. G130V (Δwzy), 13. 773 
G130V (Δwzy Δwzz), 14.N147K (Δwzy), 15. N147K (Δwzy Δwzz), 16. P165S (Δwzy), 17. 774 
P165S (Δwzy Δwzz), 18. L191F (Δwzy), 19. L191F (Δwzy Δwzz), 20. C60F (Δwzy), 21. 775 












Fig. 5. Protein expression level of the mutated WzySf-GFP compared to the positive 786 
control.  787 
The strains were grown in LB and induced as described in the Materials and Methods. In-788 
gel fluorescence samples were prepared from the mutants in the Δwzy and Δwzy Δwzz 789 
backgrounds, electrophoresed on SDS 15% (w/v) PAGE gel (See Materials and Methods).  790 
A. Strains in lanes 1-2 are as follows: 1. PNRM13 (PNRM6 [pRMPN1]), 2. PNRM134 791 
(PNRM126 [pRMPN1]). Lanes 3-20 are the Δwzy or Δwzy Δwzz strains expressing mutated 792 
WzySf-GFP. The WzySf mutants in each lane are as follows: 3. P352H (Δwzy), 4. P352H 793 
(Δwzy Δwzz), 5. V92M (Δwzy), 6. V92M (Δwzy Δwzz), 7. Y137H (Δwzy), 8. Y137H (Δwzy 794 




B. Strains in lanes 1-2 are as follows: 1. PNRM13, 2. PNRM134. Lanes 2-28 are the Δwzy 797 
or Δwzy Δwzz strains expressing mutated WzySf-GFP. The WzySf mutants in each lane are 798 
as follows: 3. N147K (Δwzy), 4. N147K (Δwzy Δwzz), 5. P165S (Δwzy), 6. P165S (Δwzy 799 
Δwzz), 7. L191F (Δwzy), 8. L191F (Δwzy Δwzz), 9. C60F (Δwzy), 10. C60F (Δwzy Δwzz), 800 
11. L49F/T328A (Δwzy), 12. L49F/T328A (Δwzy/ Δwzz), 13. L28V (Δwzy), 14. L28V (Δwzy 801 
Δwzz), 15. N86K (Δwzy), 16. N86K (Δwzy Δwzz), 17. F54C (Δwzy), 18. F54C (Δwzy Δwzz), 802 
19. F52Y (Δwzy), 20. F52Y (Δwzy Δwzz), 21. L111I (Δwzy), 22. L111I (Δwzy Δwzz), 23. 803 
G82C (Δwzy), 24. G82C (Δwzy Δwzz), 25. F52C/I242T (Δwzy), 26. F52C/I242T (Δwzy 804 
Δwzz). 805 
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